Additionally, EGFR, Mucin-1 (MUC1), and integrin beta-4 (ITGB4), which promote tumor growth and metastasis, are poor prognostic factors for this tumor (Arbelaiz et al., 2017). The gene discussed is EGFR; the disease is neoplasm.